4.7 Article

NgBR is essential for endothelial cell glycosylation and vascular development

Journal

EMBO REPORTS
Volume 17, Issue 2, Pages 167-177

Publisher

WILEY-BLACKWELL
DOI: 10.15252/embr.201540789

Keywords

cis-prenyltransferase; dolichol; glycosylation; NgBR; vascular development

Funding

  1. National Institutes of Health [R01 HL64793, R01 HL61371, R01 HL081190]
  2. American Heart Association

Ask authors/readers for more resources

NgBR is a transmembrane protein identified as a Nogo-B-interacting protein and recently has been shown to be a subunit required for cis-prenyltransferase (cisPTase) activity. To investigate the integrated role of NgBR in vascular development, we have characterized endothelial-specific NgBR knockout embryos. Here, we show that endothelial-specific NgBR knockout results in embryonic lethality due to vascular development defects in yolk sac and embryo proper. Loss of NgBR in endothelial cells reduces proliferation and promotes apoptosis of the cells largely through defects in the glycosylation of key endothelial proteins including VEGFR2, VE-cadherin, and CD31, and defective glycosylation can be rescued by treatment with the end product of cisPTase activity, dolichol phosphate. Moreover, NgBR functions in endothelial cells during embryogenesis are Nogo-B independent. These data uniquely show the importance of NgBR and protein glycosylation during vascular development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available